{"id":"NCT03989232","sponsor":"Novo Nordisk A/S","briefTitle":"A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes","officialTitle":"Efficacy and Safety of Semaglutide 2.0 mg s.c. Once-weekly Compared to Semaglutide 1.0 mg s.c. Once-weekly in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-19","primaryCompletion":"2020-09-18","completion":"2020-11-09","firstPosted":"2019-06-18","resultsPosted":"2021-10-22","lastUpdate":"2023-02-13"},"enrollment":961,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Semaglutide","otherNames":[]},{"type":"DRUG","name":"Placebo (semaglutide)","otherNames":[]}],"arms":[{"label":"Semaglutide 2.0 mg","type":"EXPERIMENTAL"},{"label":"Semaglutide 1.0 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This study compares the effect of two doses of semaglutide (1.0 mg and 2.0 mg) in people with type 2 diabetes (T2D). People taking part in the study will take the medicine together with their current diabetes medicine (sulphonylurea and/or metformin). Participants will get a dose of either 1.0 mg or 2.0 mg semaglutide once a week - which dose is decided by chance. Participants will inject semaglutide under the skin once a week. The study will last for about 49 weeks. Participants will have 9 clinic visits and 2 phone calls with the study doctor. At the visits participants will have blood taken and eye tests done. Women cannot take part if pregnant, breast-feeding or planning to become pregnant during the study period. Female participants who can get pregnant will be checked 11 times for pregnancy via urine tests.","primaryOutcome":{"measure":"Change in HbA1c","timeFrame":"Week 0, week 40","effectByArm":[{"arm":"Semaglutide 1.0 mg","deltaMin":-2,"sd":1},{"arm":"Semaglutide 2.0 mg","deltaMin":-2.2,"sd":1}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"},{"comp":"OG000 vs OG001","p":"0.0098"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":129,"countries":["United States","Bulgaria","Canada","Czechia","Greece","Hungary","Japan","Poland","Puerto Rico","Slovakia","Ukraine"]},"refs":{"pmids":["34293304"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":480},"commonTop":["Nausea","Diarrhoea","Vomiting","Decreased appetite","Dyspepsia"]}}